Pharmaceutical Composite Films and Bags Market Insights for 2034

Pharmaceutical Composite Films and Bags Market Competitive Landscape & Future Outlook

From 2025 to 2034, the global pharmaceutical composite films and bags market is set for a massive revenue upswing, with projections of growth reaching hundreds of millions of dollars. In 2024, North America led with 35% market share, polypropylene and IV bags dominated with ~30% and ~45%, parenteral sterile packaging led at 70%, and pharmaceutical manufacturers held 40%, while Asia Pacific, EVOH, biopharma bags, and biotech are set for strong CAGR growth 2025‑2034.

Last Updated: 03 October 2025 Category: Healthcare Packaging Insight Code: 5840 Format: PDF / PPT / Excel

Content

Pharmaceutical Composite Films and Bags Market Size, Demand and Trends Analysis

The pharmaceutical composite films and bags market is booming, poised for a revenue surge into the hundreds of millions from 2025 to 2034, driving a revolution in sustainable transportation. The rising demand for treatments for chronic diseases, rapid shift towards sustainable packaging, and emphasis on maintaining integrity of the drugs. Major factors such as rising e-commerce industry, and advancement in material science. There is a huge demand for high barrier films in the pharmaceutical sector enhance the demand for market.

Major Key Insights of the Pharmaceutical Composite Films and Bags Market

  • By region, North America dominated the global market by holding highest market share of approximately 35% in 2024. 
  • By region, Asia Pacific is expected to grow at a notable CAGR from 2025 to 2034.
  • By material type, the polypropylene (PP) segment contributed the biggest market share of approximately 30% in 2024.
  • By material type, the EVOH-based multilayer composites segment will be expanding at a significant CAGR in between 2025 and 2034.
  • By product, the IV bags segment contributed the biggest market share of approximately 45% in 2024.
  • By product, the biopharmaceutical storage bags segment is expected to expand at a significant CAGR in between 2025 and 2034.
  • By application, the parenteral packaging segment contributed the biggest market share of approximately 35% in 2024.
  • By application, the biopharmaceutical storage & transport segment is expanding at a significant CAGR in between 2025 and 2034.
  • By sterility, the sterile packaging segment contributed the biggest market share of approximately 70% in 2024.
  • By sterility, the sterile biopharma bags segment is expanding at a significant CAGR in between 2025 and 2034.
  • By end-use industry, the pharmaceutical manufacturers segment contributed the biggest market share of approximately 40% in 2024.
  • By end-use industry, the biotechnology companies segment is expanding at a significant CAGR in between 2025 and 2034.

What is Pharmaceutical Composite Films and Bags?

The pharmaceutical composite films and bags refer to the global industry focused on the production and utilization of multilayer, high-performance films and bags designed to protect pharmaceutical products. These materials combine polymers, foils, and barrier coatings to ensure product stability, sterility, and extended shelf life. They are widely used for drug packaging, IV bags, parenteral solutions, biopharmaceutical storage, and medical device packaging. Market growth is fueled by rising demand for advanced drug delivery systems, strict regulatory requirements for pharmaceutical packaging, and innovations in barrier and biodegradable materials.

Pharmaceutical Composite Films and Bags Market Outlook

  • Rising Chronic Diseases: There is a rapid growth of chronic diseases due to increasing number of aged populations which has enhanced strong demand for pharmaceutical packaging that can help in maintaining the integrity of the medicines.
  • Advancement in Supervisory Guidelines: The advancement in supervisory guidelines for AI printing technology and huge variety of customization option to decrease waste and provide enhanced protection to products.
  • Enhancing Personalized Medication: Enhancing demand for personalized medication for the enhancement of success rate while treating fatal diseases. Such treatments require special packaging of drugs according to unit-dose.
  • Startup Ecosystem: Development of advanced manufacturing process, sustainable materials, and intelligent packaging has boosted the market. Incorporation of smart technologies such as NFC, AI, and blockchain for monitoring the condition of the drugs, traceability, and enhanced security.

Key Metrics and Overview

Metric Details
Market Drivers Rising chronic diseases, aging population, sustainable packaging demand, high-barrier films requirement, advancements in material science, growth of e-commerce in pharma
Leading Region North America
Market Segmentation By Material Type, By Product Type, By Application, By Sterility Type, By End-User Industry and By Region
Top Key Players Amcor Plc, Sealed Air Corporation, Schott AG, Berry Global Inc., 3M Company, West Pharmaceutical Services Inc., Sartorius AG, Gerresheimer AG, Huhtamaki Oyj, Wipak Group, Constantia Flexibles Group GmbH, Mondi Group, Clondalkin Group, Tekni-Plex Inc., Catalent, Inc.

How Can AI Improve the Pharmaceutical Composite Films and Bags Market?

The incorporation of AI technology in the market plays an important role in confirming the quality of the product, improving the efficiency of the products, and enhancing supply chain handling process. It enables the automatic quality checking of the films and bags to produce high quality packaging to enhance the shelf life of the drugs. Advancement in technology has contributed significantly towards development of sustainable packaging.

Trade Analysis of Pharmaceutical Composite Films and Bags Market: Import & Export Statistics

  • China is rapidly adopting sustainable packaging and companies are investing towards R&D to produce eco-friendly films and bags. It contributes significantly for the export of films worldwide.
  • India is growing in the development of sustainable pharmaceutical packaging import primarily from the U.S. and Singapore. This market is valued around USD 5.14 billion in 2025 and is anticipated to develop to USD 7.81 billion by 2030.
  • Japan has huge advancement in the packaging technology led to high-performance packaging solutions for pharmaceutical products.
  • Germany is growing rapidly and exported around 115B USD including a wide range of pharmaceutical products.
  • UK has reported to expand this market with specialized child-resistance packaging.

Pharmaceutical Composite Films and Bags Market- Value Chain Analysis

Raw Material Sourcing

The major raw materials utilized in this market are polyethylene terephthalate, polyvinyl chloride (PVC), polypropylene, and polyethylene.

  • Key Players: Berry Global, 3M

Component Manufacturing

The major components used in this market are barrier materials, adhesives, and coating.

  • Key Players: Uflex, Huhtamaki

Logistics and Distribution

This segment plays an important role in enhancing manufacturing process to distribution process.

  • Key Players: DHL, Continental Carriers

Market Dynamics

Market Driver

Increasing Demand for Pharmaceutical Products

The increasing demand for pharmaceutical products has influenced the demand for the market. The rising prevalence of chronic diseases along with the increasing aged population has driven this market to grow rapidly. The rapid advancement in the healthcare sector promoted the enhancement of the pharmaceutical packaging films. Strict government guidelines have influenced the rapid growth of this packaging sector to enhance the storage of medicines.

Market Challenges and Restraints

High Production Charges

High production charges of the pharmaceutical films have hindered the growth of the market. The utilization of advanced materials needs huge investment which has restricted this market to grow. Strict regulatory necessities for products like serialization, stability, and safety of drugs has encouraged high-quality packaging materials usage.

Market Opportunity

Technological Innovation

Rising technological innovation has raised the opportunities for the market. Incorporation of innovation such as high-performance films, smart packaging, and AI-driven quality control. Innovation of IoT-enabled technological packaging has raised several scopes for growth of this market. Rapid changes in the healthcare demands have evolved this market significantly for the development of the market.

Material Type Insights

Why Polypropylene (PP) Segment Dominated the Pharmaceutical Composite Films and Bags Market In 2024?

The polypropylene (PP) segment dominated the market in 2024 due to its high protection potential from contamination and flexibility made it suitable for packaging of pharmaceutical products. These materials have high clarity and gloss which improve its visual appearance of the packaging. There is a high need for sterile and safe packaging that can prevent the growth of microbes. Mono-material usage for packaging of the products in the pharmaceutical industry help in the recycling of the packaging.

The EVOH-based multilayer composites segment is expected to grow at the fastest rate in the market during the forecast period. This segment is growing due to its multi-layer construction and high barrier protection. Such structure enhances the performance of the packaging film which ultimately increase its demand. These packaging preserve the quality of the drugs and support in enhancing its shelf life.

Product Type Insights

Why IV bags Segment Dominated the Pharmaceutical Composite Films and Bags Market In 2024?

The IV bags segment dominated the market in 2024 due to rising chronic diseases such as cancer and enhanced hospitalization. Continuous research towards this segment has enhanced the demand for these bags. The advancement of biodegradable films has raised the demand for these bags. Strict safety guidelines have enhanced the demand of the IV bags for packaging of pharmaceutical products. It helps in preserving sterile liquids like parenteral nutrition, saline solution, and medications.

The biopharmaceutical storage bags segment is expected to grow at the fastest rate in the market during the forecast period. This segment is growing due to increasing adoption of single-use of technologies. It decreases the risk of cross-contamination which is a major concern of the pharmacy companies. Increasing trend for contract manufacturing process of the pharmaceutical packaging.

Application Type Insights

Why Parenteral Packaging Segment Dominated the Pharmaceutical Composite Films and Bags Market In 2024?

The parenteral packaging segment held the largest share of the market in 2024 due to its potency, safety, and sterility. The rising demand for vaccines and biologics as there are increasing cases of chronic diseases. It is majorly used for protecting temperature sensitive drugs. It ensures aseptic administration and using special packaging to protect against oxygen, moisture, and light. Increasing vaccination process has raised the demand for packaging protection.

The biopharmaceutical storage & transport segment is expected to grow at the fastest rate in the market during the forecast period. This segment is growing rapidly due to advanced and barrier protecting packaging. Cold chain dominance segment is highly boosting the innovation towards packaging sector. It meets temperature barrier guidelines which enhance the utilization of the packaging.

Sterility Type Insights

Why Sterile Packaging Segment Dominated the Pharmaceutical Composite Films and Bags Market In 2024?

The sterile packaging segment held the largest share of the market in 2024 due to preventive properties of the microbial contamination. This segment is influenced by increasing surgical cases with rising chronic diseases. The rising demand for infection-free pharmaceutical supplies has raised this packaging segment significantly. Strict healthcare guidelines for enhanced packaging to maintain the integrity of the drugs has boosted the growth of the segment.

The sterile biopharma bags segment is expected to grow at the fastest rate in the market during the forecast period. This segment is growing rapidly due to increasing demand for biopharmaceuticals. Less contamination risk, operational efficiency, and flexibility have enhanced the usage of sterile biopharma. The huge need for complex biopharmaceutical goods has enhanced the demand for this market.

End-User Type Insights

Why Pharmaceutical Manufacturers Segment Dominated the Pharmaceutical Composite Films and Bags Market In 2024?

The pharmaceutical manufacturers segment held the largest share of the market in 2024 due to strict guidelines and demand for safety of the products. The upsurge in the demand for tamper-proof, reliable, and sterile packaging has raised the demand for this packaging market in the pharmaceutical industry. The continuous growth and production of this segment require enhanced protective packaging resulting in the enhancement of the market.

The biotechnology companies segment is expected to grow at the fastest rate in the market during the forecast period. This segment is growing rapidly due to increasing demand for biologics. Contant advancement to meet the changing demand of the consumers has evolved the growth of this market. Rising focus towards enhancement of packaging with contamination free has encouraged the demand for this segment.

Regional Insights

Presence of Pharmaceutical Companies Demand in North America Promote Dominance

North America held the largest share of the pharmaceutical composite films and bags market in 2024, due to the presence of several pharmaceutical companies. Strong regulatory guidance towards eco-friendly packaging development has boosted the growth of this market. Huge investment towards growth of pharmaceutical industry and its packaging has raised the demand for this market with meeting the demand of the consumers. Rising investment towards advancement of smart packaging has evolved this market rapidly.

Asia Pacific’s Healthcare Sector Advancement Enhance Market Demand

Asia Pacific expects significant growth in the market during the forecast period. This market is growing due to rising healthcare sector and its demand for superior quality packaging. Large scale manufacturing capacity has broadened the production capacity of the packages and boost the expansion of the market. Constant innovation in this market has influenced the demand of this market by fulfilling the rising demand of the consumers.

Pharmaceutical Packaging’ Regulatory Landscape: Global Regulations

Regions/ Countries Regulatory Bodies Key Regulations
Canada Health Canada Update guidance documents
Japan PMDA/ Ministry of Health, Labour & Welfare (MHLW) Transition to digital and e-labelling formats
United States FDA FDA look for food-contact materials
India CDSCO Update labelling rules and monitor
China NMPA Packaging traceability enhancement

Recent Developments

  • In September 2024, TekniPlex Healthcare, declared single-use bioprocessing pharmaceutical packaging films. It utilizes advanced material science expertise for the development of the innovation.
  • In December 2024, Symphony Environmental introduced innovation of biodegradable resin for plastics industry. It decreases fossils content of plastics and easily recyclable.

Top Companies in the Pharmaceutical Composite Films and Bags Market

  • Amcor Plc: It is well-known for developing innovative packaging solutions for complete recycling chances.
  • Sealed Air Corporation: It manufactures protective packaging solution to maintain the integrity of the drugs.
  • Schott AG: It primarily focuses towards durability of the packaging that enhance the safety during transportation.
  • Berry Global Inc.: It is a global producer of plastic packaging for drugs to prevent negative impact of moisture and air.
  • 3M Company: It covers a wide range of products packaging to enhance the experience of the consumers.
  • Others: West Pharmaceutical Services Inc., Sartorius AG, Gerresheimer AG, Huhtamaki Oyj, Wipak Group, Constantia Flexibles Group GmbH, Mondi Group, Clondalkin Group Holdings B.V., Tekni-Plex Inc., Catalent, Inc. and several others.

Pharmaceutical Composite Films and Bags Market Segments

By Material Type

  • Polyethylene (PE)
  • Polypropylene (PP)
  • Polyvinyl Chloride (PVC)
  • Polyethylene Terephthalate (PET)
  • Aluminum Foil Laminates
  • Ethylene Vinyl Alcohol (EVOH)
  • Multilayer Composite Materials

By Product Type

  • Composite Films
  • Composite Bags
  • IV Bags (Single-chamber, Multi-chamber)
  • Parenteral Bags
  • Biopharmaceutical Storage Bags
  • Blood & Plasma Bags

By Application

  • Parenteral Packaging
  • IV Infusion & Nutritional Solutions
  • Blood & Plasma Storage
  • Biopharmaceutical Storage & Transport
  • Medical Devices & Diagnostic Kits
  • Pharmaceutical Powders & Solids Packaging

By Sterility Type

  • Sterile Packaging 
  • Non-Sterile Packaging

By End-User Industry

  • Pharmaceutical Manufacturers
  • Biotechnology Companies
  • Hospitals & Clinics
  • Contract Manufacturing Organizations (CMOs)
  • Research Laboratories

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • UAE
    • Saudi Arabia
    • Kuwait

Tags

Share With : linkedin twitter facebook
  • Insight Code: 5840
  • No. of Pages: 400
  • Format: PDF/PPT/Excel
  • Last Updated: 03 October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021–2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

Meet the Team

Vidyesh Swar is a Senior Research Analyst at Towards Packaging, bringing over 4 years of dedicated expertise in market intelligence and strategic analysis across the dynamic world of packaging technologies and solutions.

Learn more about Vidyesh Swar

Aditi Shivarkar, with 14+ years in packaging market research, specializes in food, beverage, and eco-friendly packaging. She ensures accurate, actionable insights, driving Towards Packaging 's excellence in industry trends and sustainability.

Learn more about Aditi Shivarkar

Related Insights

FAQ's

Pharmaceutical composite films and bags are multilayer, high-performance packaging materials that combine polymers, foils, and barrier coatings. They ensure sterility, product stability, and extended shelf life for drugs, IV solutions, biopharmaceuticals, and medical devices. Their adoption is driven by regulatory requirements, the rise of chronic diseases, and innovations in sustainable, high-barrier packaging.

Key drivers include rising chronic disease prevalence, an aging population, growing demand for personalized medication, and increasing focus on sustainable, high-barrier packaging. Advancements in material science, smart technologies (AI, IoT), and the growth of e-commerce in pharmaceuticals also bolster market expansion.

North America held the largest share (~35%) in 2024 due to its concentration of pharmaceutical companies and strict regulatory guidelines. Asia Pacific is projected to grow at a notable CAGR between 2025–2034, fueled by rising healthcare demand, manufacturing capacity, and innovation in high-performance packaging.

IV bags accounted for the largest share (~45%) in 2024, driven by rising hospitalization rates and chronic diseases. Biopharmaceutical storage bags are expected to grow rapidly due to adoption of single-use technologies, reducing contamination risk and supporting contract manufacturing trends.

Sterile packaging (~70% share in 2024) is crucial for preventing microbial contamination, especially in parenteral products and biologics. Sterile biopharma bags are expected to grow fast due to their flexibility, operational efficiency, and reduced contamination risk for complex biologics.

AI enhances quality control, supply chain efficiency, and traceability. Automated inspection ensures high-quality films and bags, extending drug shelf life, reducing waste, and supporting sustainable packaging initiatives. AI integration in smart packaging is increasingly critical for high-value biologics.

Technological innovations such as smart, IoT-enabled, and biodegradable packaging offer growth opportunities. Advances in barrier films, single-use solutions, and AI-driven manufacturing allow companies to meet evolving healthcare and regulatory demands.